
What We're Reading: CMS Adds COVID-19 to MIPS; Trump Signals Immigration Move; Antibody Testing in Calif.
CMS will allow clinicians who participate in the Quality Payment Program to earn credit in the Merit-based Incentive Payment System (MIPS) for participation in a coronavirus disease 2019 (COVID-19) clinical trial and reporting clinical information; President Trump announced via Twitter that he would sign an executive order to temporarily suspend immigration; findings from antibody testing in Los Angeles indicate that more people have been infected with COVID-19 than initially confirmed.
CMS to Allow Practices to Earn MIPS Credit by Reporting COVID-19 Data
Trump Administration to Suspend Immigration Temporarily
President Trump said in a tweet yesterday that he will be signing an executive order “to temporarily suspend immigration into the United States,” claiming the move will protect jobs lost to the COVID-19) pandemic.
Antibody Tests Suggest Wider COVID-19 Infections in Los Angeles
According to health officials in Los Angeles, California, where antibody testing was conducted on residents, nearly 4.1% of adults tested positive for novel coronavirus antibodies, indicating that the rate of infection may be 40 times higher than the number of confirmed cases,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.